Research Comparison
CJC-1295 (without DAC) vs GHRP-2
A side-by-side research comparison of CJC-1295 (without DAC) and GHRP-2 drawn from Cobalt Peptides' peptide database records.
CJC-1295 (without DAC)
CJC-1295 (without DAC), also known as Modified GRF 1-29 (Mod GRF 1-29), is a short-acting synthetic analog of growth hormone releasing hormone (GHRH). It is designed to stimulate endogenous growth hormone (GH) release in a pulsatile, physiologically consistent manner. Unlike the DAC-modified version, this variant has a very short half-life, allowing precise control over GH pulses and reducing the risk of receptor desensitization. It is primarily used in research focused on recovery, anti-aging, body composition, and endocrine function optimization.
GHRP-2
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. It stimulates the release of endogenous growth hormone (GH) primarily through activation of the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary. Unlike GHRH analogs, GHRP-2 acts via a distinct pathway, making it highly synergistic when combined with GHRH-based peptides. It is widely used in research to investigate growth hormone pulsatility, appetite signalling, and metabolic regulation.